Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been clinically diagnosed with presumed Type 1 diabetes for at least 6 months
- People who are less than 15 weeks pregnant at the time of joining the study, based on their due date from their healthcare provider
- People who plan to use a continuous glucose monitor (CGM) regularly — at least 10 out of every 14 days — and have no plans to stop using one during the study
- People who manage their diabetes using an intensive insulin routine, either through an insulin pump (including a closed loop system) or multiple daily injections
- People who have access to technology such as a smartphone or computer that can be used to complete study questionnaires and share diabetes device data
- People who live in the United States and plan to remain in the United States for the full duration of the study
- People who can read and speak English or Spanish
- People who are willing and able to give informed consent, complete surveys, and share their diabetes device data as required by the study
Who may not be able to join:
- People who are pregnant with more than one baby (such as twins or triplets)
- People who are currently on kidney dialysis, or who expect to start kidney dialysis during the study
- People who have a history of liver cirrhosis (severe liver scarring)
- People who are currently receiving chemotherapy treatment for cancer
- People who are currently taking part in another study involving an experimental insulin delivery device, or who plan to join such a study during pregnancy
- People who have previously participated in this same study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Robin Gal, MSPH, Jaeb Center for Health Research
Phone: 813-975-8690
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
CGM Outcome (BG 63-140 mg/dl)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.